Complete Filing Data
Jade Biosciences, Inc. reported Stockholders Equity of $332.52 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Jade Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$127.4M | -$69.6M | -$75.5M | -$51.5M | -$23.0M | -$9.6M |
| Operating Income Loss | -$113.5M | -$74.6M | -$81.4M | -$53.2M | -$23.0M | -$8.9M |
| Operating Expenses | $113.5M | $74.6M | $81.4M | $53.2M | $23.0M | $8.9M |
| General And Administrative Expense | $20.4M | $21.4M | $17.2M | $14.6M | $8.0M | $949.0K |
| Research And Development Expense | $93.1M | $53.2M | $64.2M | $38.6M | $15.0M | $7.9M |
| Interest Income Expense Nonoperating Net | $7.8M | $5.0M | $5.9M | $1.8M | $65.0K | -$75.0K |
| Other Nonoperating Income Expense | -$8.0K | -$19.0K | -$1.0K | $1.8M | $62.0K | -$722.0K |
| Comprehensive Income Net Of Tax | -$127.3M | -$69.8M | -$74.8M | -$51.9M | -$23.0M | -$9.6M |
| Nonoperating Income Expense | -$13.8M | $5.0M | $5.9M | |||
| Other Nonoperating Expense | $1.0K | $79.0K | $3.0K | $3.0K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$127.4M | -$69.6M | -$75.5M | -$51.5M | -$23.0M | -$9.6M |
| Income Tax Expense Benefit | $58.0K | $55.0K | $56.0K | $25.0K | $3.0K | |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$28.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$25.2M | -$32.1M | -$38.2M | -$16.3M | -$590.0K | -$23.2M | -$19.6M | -$19.0M | -$16.5M | -$13.6M | -$12.0M | -$10.9M | -$6.2M | -$5.8M | -$2.8M | -$2.3M | -$2.2M | -$1.4M |
| Operating Income Loss | -$27.4M | -$27.8M | -$3.4M | -$15.0M | -$590.0K | -$24.6M | -$21.4M | -$20.3M | -$17.6M | -$14.2M | -$12.2M | -$11.0M | -$6.2M | -$5.8M | -$2.8M | -$2.2M | -$1.6M | |
| Operating Expenses | $27.4M | $27.8M | $3.4M | $15.0M | $590.0K | $24.6M | $21.4M | $20.3M | $17.6M | $14.2M | $12.2M | $11.0M | $6.2M | $5.8M | $2.8M | $2.2M | $1.6M | |
| General And Administrative Expense | $5.4M | $5.2M | $3.4M | $1.4M | $512.0K | $4.5M | $4.5M | $4.3M | $4.2M | $3.4M | $3.9M | $3.8M | $2.8M | $1.4M | $584.0K | $277.0K | $154.0K | |
| Research And Development Expense | $22.0M | $22.5M | $13.6M | $78.0K | $20.1M | $16.9M | $16.0M | $13.5M | $10.8M | $8.4M | $7.3M | $3.4M | $4.3M | $2.2M | $2.0M | $1.5M | ||
| Interest Income Expense Nonoperating Net | $2.3M | $1.8M | $871.0K | $388.0K | $0.00 | $1.4M | $1.8M | $1.3M | $1.1M | $560.0K | $230.0K | $109.0K | $16.0K | $2.0K | -$37.0K | |||
| Other Nonoperating Income Expense | -$28.0K | -$2.0K | $0.00 | $1.4M | -$3.0K | $1.0K | $1.3M | $1.1M | $4.0K | -$6.0K | $109.0K | $16.0K | -$1.0K | -$1.0K | -$64.0K | -$577.0K | ||
| Comprehensive Income Net Of Tax | -$25.1M | -$32.2M | -$2.6M | -$16.3M | -$590.0K | -$23.5M | -$19.6M | -$19.0M | -$16.3M | -$13.6M | -$12.1M | -$11.5M | -$6.2M | -$5.8M | -$2.8M | |||
| Nonoperating Income Expense | $2.2M | -$4.4M | $869.0K | -$1.3M | $0.00 | $1.4M | $1.8M | $1.3M | $1.1M | $564.0K | $224.0K | $109.0K | $16.0K | |||||
| Other Nonoperating Expense | $6.0K | $3.0K | $1.0K | $1.0K | $6.0K | $3.0K | $1.0K | |||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$10.9M | -$2.8M | ||||||||||||||||
| Income Tax Expense Benefit | ||||||||||||||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $18.0K | -$24.0K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $332.5M | -$46.8M | $126.7M | $172.4M | -$13.3M | -$3.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $88.4M | $69.4M | $22.4M | $54.2M | $4.6M | $3.5M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $19.1M | $10.3M | $1.1M | -$31.8M | $49.6M | $1.1M | |
| Retained Earnings Accumulated Deficit | -$174.4M | -$47.0M | -$163.4M | -$87.9M | -$36.4M | -$13.4M | |
| Prepaid Expense And Other Assets Current | $12.7M | $268.0K | $1.8M | $2.3M | $7.0M | $103.0K | |
| Liabilities Current | $16.5M | $12.0M | $17.6M | $7.8M | $2.6M | $1.8M | |
| Liabilities And Stockholders Equity | $349.8M | $72.8M | $127.4M | $135.3M | $175.4M | $4.7M | |
| Cash And Cash Equivalents At Carrying Value | $88.4M | $69.4M | $23.5M | $22.4M | $54.2M | $4.6M | |
| Assets Current | $348.8M | $69.7M | $124.2M | $131.5M | $174.3M | $4.7M | |
| Assets | $349.8M | $72.8M | $127.4M | $135.3M | $175.4M | $4.7M | |
| Accrued Liabilities And Other Liabilities Current | $9.4M | $4.1M | $14.8M | $4.8M | $1.2M | $1.2M | |
| Liabilities | $17.3M | $119.6M | $18.0M | $8.6M | $2.9M | $1.8M | |
| Accounts Payable Current | $2.2M | $1.3M | $2.4M | $2.6M | $1.2M | $618.0K | |
| Property Plant And Equipment Net | $170.0K | $288.0K | $242.0K | $186.0K | $39.0K | ||
| Common Stock Value | $5.0K | $1.0K | $3.0K | $2.0K | $2.0K | ||
| Other Assets Noncurrent | $69.0K | $3.1M | $2.3M | $2.6M | $302.0K | ||
| Operating Lease Right Of Use Asset | $726.0K | $614.0K | $1.0M | $542.0K | |||
| Debt Securities Trading Unrealized Gain Loss | $157.0K | -$132.0K | $703.0K | -$407.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $129.0K | $0.00 | $237.0K | -$466.0K | -$59.0K | ||
| Short Term Investments | $247.7M | $0.00 | $98.9M | $106.8M | $113.2M | ||
| Operating Lease Liability Noncurrent | $724.0K | $0.00 | $255.0K | $705.0K | $382.0K | ||
| Operating Lease Liability Current | $420.0K | $385.0K | $192.0K | ||||
| Other Liabilities | $70.0K | $71.0K | $13.0K | ||||
| Debt Securities Trading Unrealized Loss | $132.0K | $407.0K | $59.0K | ||||
| Accretion Of Discounts And Amortization Of Premiums On Investments Net | -$2.2M | -$3.1M | -$910.0K | $16.0K | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $773.0K | $206.0K | $765.0K | $542.0K | |||
| Debt Securities Trading Unrealized Gain | $703.0K | ||||||
| Deferred Offering Costs Included In Accounts Payable | $15.0K | ||||||
| Change In Fair Value Of Convertible Notes Payable | $21.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $179.3M | $201.6M | -$83.5M | -$16.9M | $90.9M | $109.5M | $125.7M | $141.9M | $113.1M | $139.1M | $151.1M | $161.9M | $179.8M | -$21.6M | -$16.1M | -$9.7M | -$7.3M | -$5.1M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $50.1M | $220.9M | $44.2M | $88.0M | $9.1M | $23.5M | $32.2M | $60.9M | $26.6M | $22.4M | $27.5M | $28.1M | $180.9M | $59.2M | $8.6M | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $10.5M | $88.0M | $0.00 | -$14.4M | $4.2M | -$26.1M | $4.1M | |||||||||||||
| Retained Earnings Accumulated Deficit | -$142.5M | -$117.3M | -$235.6M | -$227.6M | -$211.4M | -$186.6M | -$143.0M | -$123.4M | -$104.4M | -$72.9M | -$59.3M | -$47.3M | -$28.2M | -$22.0M | ||||||
| Prepaid Expense And Other Assets Current | $2.5M | $2.0M | $1.2M | $1.9M | $6.6M | $3.9M | $2.4M | $2.4M | $1.6M | $2.6M | $1.5M | $4.8M | $2.2M | $159.0K | ||||||
| Liabilities Current | $22.4M | $21.6M | $2.4M | $10.3M | $17.0M | $15.5M | $14.7M | $13.3M | $10.6M | $7.7M | $3.8M | $4.7M | $3.8M | $4.2M | ||||||
| Liabilities And Stockholders Equity | $202.5M | $224.0M | $77.5M | $91.0M | $111.7M | $106.8M | $140.9M | $155.8M | $124.4M | $147.7M | $155.7M | $167.0M | $184.1M | $62.4M | ||||||
| Cash And Cash Equivalents At Carrying Value | $50.1M | $220.9M | $44.2M | $31.1M | $31.1M | $9.1M | $32.2M | $60.9M | $26.6M | $22.4M | $27.5M | $28.1M | $180.9M | $59.2M | ||||||
| Assets Current | $201.4M | $223.0M | $77.4M | $90.6M | $110.8M | $103.2M | $137.6M | $152.5M | $120.6M | $145.2M | $153.4M | $165.9M | $183.1M | $59.3M | ||||||
| Assets | $202.5M | $224.0M | $77.5M | $91.0M | $111.7M | $106.8M | $140.9M | $155.8M | $124.4M | $147.7M | $155.7M | $167.0M | $184.1M | $62.4M | ||||||
| Accrued Liabilities And Other Liabilities Current | $14.0M | $8.1M | $2.0M | $8.9M | $12.4M | $11.8M | $10.8M | $7.4M | $5.5M | $2.8M | $1.3M | $1.6M | $1.1M | $1.2M | ||||||
| Liabilities | $23.1M | $22.4M | $2.5M | $10.5M | $17.3M | $15.9M | $15.2M | $13.8M | $11.3M | $8.5M | $4.6M | $5.1M | $4.3M | |||||||
| Accounts Payable Current | $1.4M | $7.6M | $69.0K | $908.0K | $4.2M | $3.3M | $3.5M | $5.5M | $4.7M | $4.5M | $2.1M | $2.9M | $2.6M | |||||||
| Property Plant And Equipment Net | $176.0K | $147.0K | $2.0K | $0.00 | $14.0K | $232.0K | $260.0K | $316.0K | $245.0K | $267.0K | $330.0K | $316.0K | $288.0K | $162.0K | $35.0K | |||||
| Common Stock Value | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | |||||||
| Other Assets Noncurrent | $174.0K | $60.0K | $81.0K | $81.0K | $2.6M | $2.2M | $2.2M | $2.6M | $1.1M | $731.0K | $327.0K | $278.0K | $3.1M | |||||||
| Operating Lease Right Of Use Asset | $740.0K | $777.0K | $158.0K | $0.00 | $259.0K | $621.0K | $725.0K | $713.0K | $811.0K | $908.0K | $1.1M | $1.2M | $499.0K | $583.0K | ||||||
| Debt Securities Trading Unrealized Gain Loss | -$55.0K | $307.0K | -$50.0K | -$270.0K | -$22.0K | -$22.0K | $265.0K | $14.0K | -$141.0K | -$585.0K | ||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $29.0K | -$24.0K | $50.0K | $224.0K | -$83.0K | -$33.0K | -$195.0K | -$223.0K | -$201.0K | -$771.0K | -$785.0K | -$644.0K | ||||||||
| Short Term Investments | $148.8M | $32.0M | $57.6M | $73.1M | $90.2M | $103.0M | $89.2M | $92.4M | $120.2M | $124.5M | $132.9M | |||||||||
| Operating Lease Liability Noncurrent | $747.0K | $792.0K | $81.0K | $206.0K | $329.0K | $358.0K | $476.0K | $591.0K | $800.0K | $862.0K | $335.0K | $452.0K | ||||||||
| Operating Lease Liability Current | $312.0K | $417.0K | $459.0K | $475.0K | $445.0K | $451.0K | $379.0K | $373.0K | $379.0K | $347.0K | $193.0K | $147.0K | ||||||||
| Other Liabilities | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $70.0K | $69.0K | $70.0K | $13.0K | $13.0K | $14.0K | |||||||||
| Debt Securities Trading Unrealized Loss | $55.0K | $50.0K | $270.0K | $22.0K | $141.0K | $585.0K | ||||||||||||||
| Accretion Of Discounts And Amortization Of Premiums On Investments Net | -$225.0K | -$759.0K | -$671.0K | $29.0K | ||||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $206.0K | |||||||||||||||||||
| Debt Securities Trading Unrealized Gain | $307.0K | $28.0K | $265.0K | $14.0K | ||||||||||||||||
| Deferred Offering Costs Included In Accounts Payable | $82.0K | $104.0K | $207.0K | |||||||||||||||||
| Change In Fair Value Of Convertible Notes Payable | $0.00 | $6.2M | $1.7M | $0.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $20.0M | $11.3M | $11.9M | $5.5M | $2.0M | $58.0K |
| Net Cash Provided By Used In Operating Activities | -$94.7M | -$71.2M | -$56.8M | -$39.1M | -$27.4M | -$7.9M |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $3.9M | -$9.9M | $10.0M | $3.7M | -$6.0K | $1.0M |
| Increase Decrease In Accounts Payable | $361.0K | -$2.2M | -$164.0K | $1.4M | $609.0K | $37.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $12.0M | -$299.0K | -$483.0K | -$4.7M | $6.9M | $103.0K |
| Net Cash Provided By Used In Financing Activities | $360.8M | $25.4M | $46.0M | $396.0K | $190.5M | $8.9M |
| Net Cash Provided By Used In Investing Activities | -$247.0M | $56.0M | $11.9M | $6.9M | -$113.4M | |
| Increase Decrease In Other Noncurrent Assets | $38.0K | -$563.0K | $110.0K | $1.9M | $302.0K | |
| Payments To Acquire Property Plant And Equipment | $196.0K | $142.0K | $195.0K | $181.0K | ||
| Increase Decrease In Operating Lease Asset And Liability | -$109.0K | -$26.0K | $43.0K | $32.0K | ||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $75.7M | $136.0M | $154.7M | |||
| Payments To Acquire Short Term Investments | $19.7M | $124.0M | $147.6M | $113.3M | ||
| Proceeds From Stock Options Exercised | $88.0K | $1.5M | $986.0K | $617.0K | $5.0K | |
| Payments Of Stock Issuance Costs | $307.0K | $234.0K | $371.0K | |||
| Increase Decrease In Other Operating Liabilities | $163.0K | -$384.0K | -$133.0K | |||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | 296.0K | 308.0K | 356.0K | 150.0K | ||
| Proceeds From Issuance Of Common Stock | $23.9M | $44.9M | $126.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $4.3M | $3.9M | $1.2M | $27.0K | $3.9M | $4.2M | $3.2M | $3.0M | $2.4M | $1.5M | $1.2M | $1.0M | $23.0K |
| Net Cash Provided By Used In Operating Activities | -$2.4M | -$6.8M | $0.00 | -$23.7M | -$11.4M | -$5.7M | -$3.8M | ||||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$1.2M | $244.0K | $590.0K | -$3.1M | $716.0K | $497.0K | -$924.0K | ||||||
| Increase Decrease In Accounts Payable | -$155.0K | $298.0K | $835.0K | $2.1M | $1.6M | $765.0K | |||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$331.0K | $215.0K | $2.1M | -$636.0K | -$2.1M | $860.0K | |||||||
| Net Cash Provided By Used In Financing Activities | $94.8M | $0.00 | $471.0K | $223.0K | $7.9M | ||||||||
| Net Cash Provided By Used In Investing Activities | $12.9M | $0.00 | $0.00 | $8.8M | $15.4M | -$20.4M | -$40.0K | ||||||
| Increase Decrease In Other Noncurrent Assets | -$2.0K | $89.0K | $25.0K | ||||||||||
| Payments To Acquire Property Plant And Equipment | $16.0K | $28.0K | $40.0K | ||||||||||
| Increase Decrease In Operating Lease Asset And Liability | -$54.0K | -$12.0K | -$31.0K | -$3.0K | |||||||||
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $12.9M | $23.6M | $31.0M | $12.5M | |||||||||
| Payments To Acquire Short Term Investments | $14.8M | $15.6M | $32.9M | ||||||||||
| Proceeds From Stock Options Exercised | $704.0K | $223.0K | |||||||||||
| Payments Of Stock Issuance Costs | $233.0K | $100.0K | |||||||||||
| Increase Decrease In Other Operating Liabilities | $202.0K | $392.0K | $9.0K | ||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans | |||||||||||||
| Proceeds From Issuance Of Common Stock |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.19 | -$2.44 | -$2.87 | -$2.10 | -$1.87 | -$40.31 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Authorized | 300.0M | 40.0M | 150.0M | 150.0M | 150.0M | 50.0M |
| Weighted Average Number Of Shares Outstanding Basic | 31.4M | 28.6M | 26.3M | 24.5M | 12.3M | |
| Earnings Per Share Basic | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | |
| Weighted Average Number Of Diluted Shares Outstanding | 31.4M | 28.6M | 26.3M | 24.5M | 12.3M | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 49.3M | 3.7M | 27.8M | 24.7M | 24.4M | 243.1K |
| Common Stock Shares Issued | 49.3M | 3.7M | 27.8M | 24.7M | 24.4M | 243.1K |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.48 | -$0.86 | -$0.09 | -$5.16 | -$0.19 | -$0.83 | -$0.71 | -$0.76 | -$0.67 | -$0.56 | -$0.49 | -$0.45 | -$0.26 | -$23.80 | -$10.13 | -$9.12 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Authorized | 300.0M | 300.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 39.6M | 28.4M | 29.0M | 3.2M | 3.2M | 27.8M | 27.6M | 25.2M | 24.8M | 24.5M | 24.4M | 24.4M | 23.9M | 243.1K | 243.1K | |||
| Earnings Per Share Basic | $-0.48 | $-0.86 | $-0.09 | $-5.16 | $-0.19 | $-0.83 | $-0.71 | $-0.76 | $-0.67 | $-0.56 | $-0.49 | $-0.45 | $-0.26 | $-23.80 | $-11.49 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 39.6M | 28.4M | 29.0M | 3.2M | 3.2M | 27.8M | 27.6M | 25.2M | 24.8M | 24.5M | 24.4M | 24.4M | 23.9M | |||||
| Preferred Stock Shares Authorized | 12.6K | 12.6K | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Common Stock Shares Outstanding | 32.6M | 32.6M | 29.0M | 28.9M | 28.9M | 27.9M | 27.7M | 27.6M | 24.8M | 24.5M | 24.4M | 24.4M | 24.4M | 243.1K | ||||
| Common Stock Shares Issued | 32.6M | 32.6M | 29.0M | 28.9M | 28.9M | 27.9M | 27.7M | 27.6M | 24.8M | 24.5M | 24.4M | 24.4M | 24.4M | 243.1K | ||||
| Preferred Stock Shares Outstanding | 12.6K | 12.6K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 12.6K | 12.6K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $9.9M | $11.3M | $11.9M | $5.5M | $2.0M | $58.0K |
| Additional Paid In Capital | $506.8M | $179.0K | $272.6M | $215.1M | $208.9M | $63.0K |
| Stock Issued During Period Value Stock Options Exercised | $88.0K | $1.5M | $986.0K | $617.0K | $5.0K | |
| Depreciation | $26.0K | $282.0K | $96.0K | $68.0K | $15.0K | $1.0K |
| Stock Issued During Period Value Employee Stock Purchase Plan | $296.0K | $308.0K | $356.0K | $150.0K | ||
| Stock Issued During Period Value New Issues | $23.6M | $44.3M | $126.9M | |||
| Stock Issued During Period Shares Stock Options Exercised | 382.8K | 339.0K | 298.7K | |||
| Capital Expenditures Incurred But Not Yet Paid | $21.0K | $40.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.9M | $2.4M | $1.5M | $3.0K | $3.9M | $4.2M | $3.2M | $3.0M | $2.4M | $1.5M | $1.2M | $1.0M | $845.0K | $321.0K | $23.0K | $21.0K | $6.0K | $7.0K |
| Additional Paid In Capital | $321.8M | $318.9M | $310.6M | $307.9M | $305.9M | $277.5M | $268.9M | $265.6M | $217.7M | $212.8M | $211.1M | $209.9M | $208.0M | $407.0K | ||||
| Stock Issued During Period Value Stock Options Exercised | $22.0K | $511.0K | $704.0K | $95.0K | $333.0K | $223.0K | $160.0K | $14.0K | $5.0K | |||||||||
| Depreciation | $4.0K | $28.0K | $21.0K | $11.0K | $2.0K | |||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $308.0K | $228.0K | ||||||||||||||||
| Stock Issued During Period Value New Issues | $23.6M | $44.3M | $126.9M | |||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 133.3K | 94.0K | 1.6K | |||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $30.0K | $85.0K |
Most recent annual filing with the SEC: March 6, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.